MyOr Diagnostics provides noninvasive monitoring technologies that use data-driven artificial intelligence to predict and prevent chronic conditions in infants and children.

The company has developed a cutting-edge AI-driven platform designed to predict and mitigate the risk of food allergies, eczema, and related conditions in infants.

With a dedicated team and innovative technologies, MyOr promotes evidence-based practices and infant nutrition strategies that can prevent many chronic conditions.

The company is committed to improving health outcomes and empowering healthcare providers and caregivers with personalized solutions to eliminate preventable conditions, creating a healthier future for children worldwide.